** Shares of biotech company ONVO.O up 9.6 pct at $1.25 in
premarket trading
** Co enters into a cell and tissue clinical sourcing deal
with International Institute for the Advancement of Medicine
** Under deal, co to get donated organs that have not been
utilized for transplantation with potential benefit for
generating cell-based building blocks for co's liver tissue
development program urn:newsml:reuters.com:*:nGNXc88s8p
** Co says on track to pursue orphan designation for second
rare disease indication; to commence Investigational New Drug
enabling studies for treating end stage liver disease
** Stock down nearly 15 pct this year
(Reporting by Susan Mathew in Bengaluru;)
((Reuters Messaging:
susan.mathew.thomsonreuters.com@reuters.net))